Arecor Proprietary Pipeline

Using our Arestat™ technology platform, we are developing enhanced medicines for the treatment of diabetes and other chronic conditions

Tetris Pharma Portfolio

Our specialty pharmaceutical experts in registering, marketing, sales and the distribution of commercial-stage speciality hospital products across the UK and Europe

Our Partners

We partner with leading pharmaceutical and biotechnology companies through technology partnerships to enhance their proprietary products across a range of indications and stages of development

Latest News and Events

  • 23rd January 2024

    ARECOR ANNOUNCES UPDATE ON INBRX-101

  • 18th January 2024

    ARECOR GRANTED KEY EUROPEAN PATENT EXTENDING PROTECTION FOR INSULIN PRODUCTS, AT278 AND AT247

  • 8th January 2024

    ARECOR ANNOUNCES EXPANSION OF EXISTING SPECIALTY HOSPITAL FORMULATION COLLABORATION